https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:54499 Tue 27 Feb 2024 15:18:23 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:44153 90% probability of a safety signal being detected by AusVaxSafety based on solicited reports for either fever or medical attendance at or before the week ending 28 March 2010, 3 weeks after the start of vaccine distribution. Suspension of the national paediatric influenza vaccination programme as a result of the passive adverse events surveillance operating at the time did not occur until 23 April 2010. Conclusions: Active vaccine safety surveillance leading to rapid detection of a safety signal would likely have resulted in earlier suspension of Fluvax from the vaccination programme, prevention of many febrile convulsions and maintenance of public confidence in influenza vaccination for young children.]]> Mon 10 Oct 2022 09:31:36 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49361 Fri 12 May 2023 12:35:08 AEST ]]>